Denison Mines

Phase A — Understand the business

Lens 1 · Company Overview

Denison Mines is a pre-production uranium developer, not a miner with a P&L. The whole equity is an option on one flagship project plus a stack of optionality assets and a physical uranium hoard.

• Flagship — Wheeler River / Phoenix ISR (95% Denison). The Phoenix deposit in Saskatchewan's eastern Athabasca Basin is the asset. Denison took a Final Investment Decision and began site preparation/construction in March 2026, targeting first production mid-2028 on a ~2-year build. Phoenix is the first uranium mine in Canada approved for in-situ recovery (ISR) and the first large-scale Canadian uranium mine approved for construction in 20+ years.
• Cash-flow today — McClean Lake (22.5%). Denison's only operating exposure is a 22.5% stake in the McClean Lake Joint Venture (Orano Canada 77.5%), which owns the McClean Lake mill — one of the world's largest, licensed for up to ~24M lb U₃O₈/yr — that toll-mills ore from Cameco's Cigar Lake mine. In Q1 2026 the mill processed 5.0M lb U₃O₈ for the CLJV and Denison booked toll-milling revenue of C$1.106M. SABRE mining at McClean North began July 2025 but was "minimal" in Q1 2026, with resumption planned Q2 2026.
• Treasury asset — physical uranium. Denison holds ~1.7M lb of physical U₃O₈ (market value ~C$190.3M at year-end), having sold 500,000 lb for C$54.25M in proceeds. ~500,000 lb remain uncommitted.
• Other. Stakes/exposure across the Athabasca (Waterbury, Wheeler's deeper Gryphon deposit) plus technology/royalty interests. Reporting under IFRS, audited by KPMG LLP, internal controls assessed effective.
• How it makes money (today vs. 2028): Today, revenue is a rounding error (FY2025 ≈ C$3.5M ); the income statement is dominated by mark-to-market swings on the physical uranium, equity investments, and convertible-note derivatives. From mid-2028, the model becomes a low-cost ISR producer selling into term contracts.

Contract structure: Denison has built a forward sales book ahead of first pounds — nearly 8M lb U₃O₈ contracted plus ~8M lb in advanced negotiation (≈16M lb total). Pricing is a mix of market-related (no floors/ceilings), market-related with floors/ceilings, and base-escalated — i.e. it keeps meaningful upside to spot while flooring some volume. Customers are "several leading North American nuclear operators (50+ reactors) plus reputable intermediaries".

Lens 2 · Supply Chain

Map the chain with named stakeholders (this lens fails if generic):

Upstream (inputs to build & operate Phoenix):

• Engineering / EPCM: Wood Canada Limited (construction management contractor). Technical reports authored by SRK, SLR, Stantec, Hatch, Wood, Engcomp, Newmans Geotechnique, Egis Canada (qualified-person consents in the 40-F exhibit index).
• Power: SaskPower grid connection secured Jan 2026 — a real de-risking step (removes diesel-genset reliance).
• Freeze-wall / ISR reagents & sulphuric acid: ISR leaches with acid; reagent supply and the freeze plant are critical-path inputs (single-process chokepoint — see Lens 13).

Midstream (the company): Phoenix wellfield → freeze wall containment → ISR leach → processing plant on-site → packaged U₃O₈. McClean Lake mill (22.5%) is a separate node that mills third-party (Cameco/Cigar Lake) ore, not Phoenix ore — Phoenix is designed as a standalone ISR plant.

Downstream (buyers): Packaged U₃O₈ → conversion → enrichment → fuel fabrication → utilities. Denison sells yellowcake (U₃O₈); it does not own conversion/enrichment. Direct buyers are North American utilities (50+ reactors) and traders/intermediaries. The physical-uranium treasury also gives it a trading relationship with the spot market (and with SPUT-driven demand).

Chokepoints / single-source: (1) One producing asset matters and it isn't built — Phoenix is the chain; (2) McClean Lake mill is operated by Orano, Denison is a 22.5% minority — no operating control; (3) Cigar Lake (Cameco) is the toll-mill's feed — McClean Lake revenue depends on a competitor's mine running; (4) freeze plant + acid supply are Phoenix single-process dependencies.

Lens 3 · Competitive Advantages (moats)

For a developer, "moat" = asset quality + permits + balance sheet, not brand.

• Grade. Athabasca Basin hosts the world's highest-grade uranium. Phoenix probable reserves grade ~11.4% U₃O₈ (proven 24.5%) — orders of magnitude above ISR norms in Wyoming/Kazakhstan (sub-0.1%). Grade is the durable edge: it underwrites "among the lowest cash + all-in costs of any uranium mine".
• Permitting moat (the real one right now). CNSC approval for the Environmental Assessment + Licence to Prepare a Site & Construct (Feb 2026) makes Phoenix the only ISR-permitted uranium mine in Canada and the first large-scale Canadian uranium construction approval in 20+ years. In a jurisdiction where permitting takes a decade, an approved licence is a scarce, hard-to-replicate asset.
• Method/cost moat (unproven). If ISR works at Athabasca grade, Phoenix has structurally lower capex/opex than conventional underground (e.g. NexGen's Arrow) — no shafts, smaller footprint, faster ramp. Caveat: this moat is conditional on first-of-a-kind technology succeeding (Lens 13).
• Balance-sheet moat. Post the Aug 2025 raise, total cash + investments + uranium ≈ C$720M with no traditional debt (convertibles aside); Phoenix is fully funded to production [implied by FID]. Most junior developers cannot self-fund a build — Denison can.
• Bargaining power: Weak vs. Orano at McClean Lake (minority partner). Moderate vs. utilities — in a tight market with term price at 18-yr highs, sellers of permitted Western pounds have leverage; Denison kept upside by contracting partly at market-related-no-cap pricing.

Lens 4 · Segments

segments.csv is empty. From disclosure, Denison reports along these lines:

• Mining (McClean Lake JV, 22.5%): the only revenue-generating segment today — toll milling C$1.1M in Q1 2026; SABRE mining ramping.
• Evaluation & Development (Wheeler/Phoenix): the capital-consuming segment — now in construction; this is where the ~C$600M build spend flows.
• Corporate / Investments / Physical Uranium: holds the ~1.7M-lb uranium book and equity stakes; this is the segment that produces the giant non-cash FV swings dominating reported earnings.

Trend: revenue is immaterial and flat-to-noisy; the meaningful "segment" is the development spend ramping sharply (FID → construction) and the treasury mark swinging with uranium price. There is no operating-segment growth story until 2028.

---

Phase B — Measure performance

Lens 5 · Earnings Result (FY2025 + Q1 2026)

This is the most important interpretive point in the dossier: the headline loss is almost entirely non-cash mark-to-market, not operating deterioration.

• Revenue FY2025 ≈ C$3.5M — immaterial; this is a developer.
• Net loss FY2025 — SOURCE CONFLICT, surfaced not resolved: one set of reports states a net loss of C$155.9M (−C$0.17/sh); another, reading the same 6-K, states C$217.3M. The two likely differ by what's included (pre- vs. post a Q1-2026-dated derivative item bleeding into the figure, or attributable vs. total). Do not treat either as audited here — the audited number is in 40-F Exhibit 99.3, not on the shelf. n/a — exact audited FY2025 net loss not sourced from a primary filing.
• Driver of the loss (clear regardless of magnitude): fair-value losses on the embedded derivatives of the August 2025 US$300M convertible notes — a C$36.0M day-one loss at issuance, plus a further ~C$108.4M FV derivative loss recorded in Q1 2026. Plus FV swings on equity investments and the physical uranium. These move with DNN's own share price and uranium — a rising share price increases the convertible-derivative liability and worsens reported earnings. This is the opposite of an operating red flag (Lens 10 treats it as a presentation/volatility issue, not fraud).
• Margins: n/a — no production, no meaningful gross/operating margin.
• Balance sheet (the actual story): total cash + investments + physical uranium ≈ C$720M, no traditional debt post the Aug 2025 raise; ~1.7M lb physical U₃O₈ (~C$190M). Funded to build Phoenix.
• Guidance: Phoenix initial capital revised to ~C$600M (Jan 2026 post-FID) vs. the 2023 FS estimate of <C$420M (100% basis) — a material ~40%+ cost increase. Management attributes it to inflation, refinements, and improved estimation precision; the after-tax NPV-to-initial-capital ratio compresses from ~3.7:1 (2023 FS) to ~2.6:1 (Jan 2026). First production held at mid-2028.
• Market reaction: stock soared on the Jan 2026 FID / construction news ("Why Denison Mines Stock Soared Today," Jan 2, 2026 ); trades ~US$3.10 vs. a 52-wk range US$1.67–4.43 — i.e. near the upper half, with the permitting/FID catalysts largely priced.

Unusual vs. own history: the capex creep (+40%) and the convertible-derivative volatility are both new since 2023; the permitting milestone (CNSC, Feb 2026) is the single biggest de-risking event in the company's history.

Lens 6 · Earnings Calls (sentiment trend)

No transcripts on the shelf; assessment from releases/interviews ``.

• What management talks about now: "on track for mid-2028," "first ISR mine in Canada," "fully funded," "16M lb contracted/in-negotiation," "lowest-cost." The tone shifted decisively from probabilistic (2023–24: "advancing toward FID," "regulatory in process") to committed/operational (2026: "construction commenced," "site prep complete by end-April").
• CEO David Cates externally frames a structural supply deficit: "uranium supply [is] behind, demand evolving". Recurring themes: term price at 18-yr highs, utility restocking, Western-supply security.
• What they stopped saying: the hedged "if we proceed" language — FID removed the conditionality. The new risk they cannot talk away is execution (build on time/budget; ISR commissioning).

Lens 7 · Comps

Uranium peers — market caps ``, late June 2026. Valuation multiples (EV/Sales, EV/EBIT, P/E, ROE) are largely n/a for the developers: DNN, NexGen and (mostly) the juniors have no production revenue/EBITDA, so those ratios are meaningless — the correct lens for a developer is market cap vs. project NPV and resource quality, not earnings multiples. Fabricating a P/E here would be the classic error the skill warns against.

The comp that matters: DNN's ~US$2.8B cap vs. Phoenix after-tax NPV8 = C$1.48B for Denison's 95% (2023 FS, ≈ US$1.08B at 0.73). So the market pays ~2.6x the single-project NPV. The premium capitalises (a) Wheeler's larger resource incl. the deeper Gryphon deposit, (b) the ~1.7M-lb / ~C$190M uranium treasury, (c) McClean Lake, and (d) leverage to a rising uranium price not in the FS deck. Versus NexGen ($6.4B) and UEC ($5.9B), DNN is the cheapest of the credible developers on absolute cap — which is the bull's whole pitch and the bear's "it's small and single-asset for a reason."

Lens 8 · Stock-Price Catalysts (>5% moves, ~5y)

Pattern ``:

• 2021 (early): caught in the meme/short-squeeze frenzy — DNN +~75% off late-Jan 2021. Lesson: DNN is a high-beta uranium proxy, not a fundamentally-driven name in risk-on episodes.
• 2021–2023 — the SPUT campaign: Sprott Physical Uranium Trust drove spot from ~$32 (Jul 2021) to ~$106; DNN tracked the move. DNN's single biggest price driver historically is the uranium price, amplified by SPUT flows.
• 2022–2023: Phoenix milestones (metallurgical test work, Feasibility Field Test approval, FS economics +150% NPV); DNN +~40% in 2023.
• 2025 (Jul): Saskatchewan ministerial EA approval.
• 2026 (Feb): CNSC approval → FID → construction (Mar 2026); "stock soared" Jan 2. SaskPower grid connection (Jan) de-risked.
• What the market actually reacts to: (1) uranium spot/term price (the dominant factor, often via SPUT), (2) Phoenix regulatory/FID milestones, (3) macro risk-on/off. It reacts far less to the trivial earnings line — the FV-driven net loss is correctly ignored by the tape.

---

Phase C — Judge people & books

Lens 9 · Management

• CEO David Cates — appointed Jan 2015, ~11-yr tenure; rose internally (former VP Finance & Tax, then CFO); earlier at Kinross Gold and PwC. A finance-bred operator (CFO→CEO), fitting for a capital-markets-and-permitting-intensive developer.
• Track record: advanced Wheeler from PFS (2018) → FS (2023, NPV +150%) → CNSC approval → FID/construction (2026); repeatedly kept the mid-2028 timeline through the permitting gauntlet; built a ~C$720M war chest and a 16M-lb forward book before producing a pound. Execution credibility on financing and permitting is strong; on building/commissioning a first-of-a-kind mine, unproven (no operating-mine build under his belt).
• Skin in the game: Cates owns ~0.23% (~US$8.2M); over ~18 months he made 2 insider transactions netting a sale of 350,000 shares. Modest ownership and net selling — not a red flag at this scale, but not founder-level alignment either.
• Comp: total ~C$2.27M (26% salary / 74% bonus+equity); "below average for similar-size US peers". Reasonable.
• Board: audit committee chaired by Patricia Volker (with Ken Hartwick, David Neuburger), all independent, two designated financial experts. Avg board tenure ~4.6y, management ~2.3y.
• Capital allocation: the defining choices — (a) holding physical uranium as a treasury asset (smart in a bull market; a volatility/leverage source in a bear); (b) funding via US$300M convertibles rather than pure equity (limits near-term dilution but injects the derivative-driven earnings noise and a 2031 maturity); (c) proceeding to FID at C$600M vs. <C$420M FS. Archetype: professional manager / capital allocator, not founder-promoter — appropriate for this stage, but the promotional "lowest-cost, first-in-Canada" messaging should be read with that in mind.

Lens 10 · Forensic Red Flags

Acting as a forensic analyst on a pre-revenue developer — the usual revenue-recognition/receivables playbook mostly doesn't apply (there's no revenue to manipulate). The real items:

• Fair-value-through-P&L everywhere. The physical uranium (~C$190M), equity investments, and the convertible-note embedded derivatives are all carried at FVTPL. This makes reported net income extremely volatile and non-cash — the C$36.0M day-one loss + C$108.4M Q1-2026 derivative loss are accounting artifacts of a rising share price, not cash burn. Watch for: management steering investors to "adjusted" figures that strip these — legitimate here, but verify the adjustments aren't also stripping real cash costs.
• Convertible notes (US$300M, due 2031). Dilution overhang + a complex derivative liability. Not hidden, but the structure is why the income statement is unreadable at the headline line. Net-loss figures will swing wildly quarter to quarter for non-operating reasons.
• Capex credibility. The +40% capex revision (<C$420M → ~C$600M) is the single most important "books" flag — first-of-a-kind ISR projects are notorious for further overruns once commissioning starts (Lens 13). The NPV-to-capital ratio already compressed 3.7:1 → 2.6:1.
• Reserve/resource basis. Reported under Canadian NI 43-101 (qualified-person consents from SRK, SLR, Hatch, et al. in the 40-F ) — credible, but ISR recovery assumptions at Athabasca grade are unproven at production scale; the reserve→recovered-pounds conversion carries technical risk a balance sheet can't capture.
• Controls: Management + KPMG assessed internal control over financial reporting effective as of 2025-12-31; no material changes; no restatements; no Reg-BTR notices. Clean.

Regulatory findings (required sub-section):

• SEC Litigation Releases: None for Denison Mines, 2021-06-29→2026-06-29.
• SEC AAERs: None in the same period.
• Non-SEC enforcement (web): No material FTC/DOJ/securities enforcement actions surfaced. The notable adversarial item is MiningWatch Canada's October 2025 submission to the CNSC challenging Wheeler River's environmental case (ISR/freeze-wall novelty, groundwater containment) — that is regulatory/ENGO opposition, not an enforcement finding, but it is the live external challenge to watch through commissioning.
• 40-F Item / Legal Proceedings: the 40-F shell incorporates risk factors by reference (AIF Exhibit 99.1) rather than restating them; no litigation is disclosed on the face of the scraped document. Material-litigation detail n/a — in AIF exhibit, not on shelf.
• Conclusion: No material regulatory or legal/enforcement findings — verified via SEC EDGAR EFTS (LR, AAER) and web search as of 2026-06-29. The only external challenge is an ENGO environmental submission, not an enforcement action.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

EPS is the wrong metric for a pre-2028 developer — reported EPS will be FV-noise until production. Project the asset, not the P&L.

• FY2026E / FY2027E: net loss continues; magnitude dominated by uncontrollable FV swings on uranium + convertible derivatives + construction spend ramping toward the ~C$600M build. EPS n/a — not a meaningful estimate; non-cash-FV-dominated.
• FY2028E (first production mid-2028): partial-year production; the model flips. At Phoenix steady-state economics — ~8.4M lb/yr peak (first 5y), ~56.7M lb recovered over ~10y, among the lowest cash + all-in costs — and uranium at term ~US$93/lb, gross cash margins are very wide.
• Rough steady-state cash-flow sketch ``: ~8.4M lb/yr × ~US$93/lb ≈ ~US$780M/yr gross revenue at plateau (100% basis); Denison's ~95% ≈ ~US$740M. Net of low ISR opex + royalties/taxes, the after-tax NPV8 of C$1.48B (Denison 95%) is the anchored value — the stock at ~US$2.8B already trades at ~2.6x that single-asset NPV, so the incremental upside requires either (a) higher uranium prices than the FS deck, (b) Gryphon/Wheeler expansion converting to value, or (c) the option premium holding. The downside if ISR disappoints is a collapse toward the treasury + McClean Lake + remaining-resource value, well below today.
• Forecast log: Skipped per --watchlist rules (no genuine committed base case in unattended breadth mode). The natural scoreable binary if promoted: "Phoenix achieves first commercial production by 2028-12-31."

Every input above is labelled; no fabricated EPS multiple was created.

Lens 12 · Bull vs Bear

Bull case. Denison owns the only ISR-permitted uranium mine in Canada, in the world's highest-grade district, fully funded, under construction, into the tightest uranium market in 18 years (term ~US$93/lb, SPUT holding 76M lb, structural supply deficit). It is the cheapest credible developer (~US$2.8B vs. NexGen $6.4B / UEC $5.9B) with a 16M-lb forward book partly priced at market-no-cap, preserving spot upside. If ISR works, Phoenix is a multi-decade, lowest-quartile-cost producer and the NPV re-rates as construction risk falls and uranium runs. Optionality (Gryphon, McClean Lake, physical uranium) is largely free in the current price.

Bear case (permanent-impairment risks). (1) First-of-a-kind technology: ISR has never been used in Canada and freeze-wall containment has never been used anywhere for an ISL uranium mine — bears put technical PoS at 30-40%; Cameco's Millennium failure in similar fractured Athabasca geology is the cautionary analog. A commissioning failure or containment problem is a near-total, permanent impairment of the thesis. (2) Uranium price: the entire developer-premium evaporates if spot/term roll back below ~$60-70 (the 2021 SPUT-driven spike has shown how fast sentiment unwinds). (3) Capex/schedule: the build already ran +40% pre-construction; further overruns or a slip past mid-2028 compress NPV and may force dilutive financing despite the current war chest.

Pre-mortem (18 months out, thesis broke): Phoenix commissioning revealed the freeze wall couldn't reliably contain leach solution in fractured rock / recoveries fell short of the FS → schedule slipped to 2029-30 and capex blew through C$700M → a dilutive equity raise hit at a low uranium tape (spot back to ~$60) → the stock round-tripped to ~$1.50, back toward asset-backing value. Secondary path: uranium simply faded (utility contracting paused, SPUT stopped buying) and the developer premium compressed even with the build on track.

Are multiples too high? On NPV, the market already pays ~2.6x the single-asset value — not cheap on a de-risked basis; it's only cheap if you believe uranium runs and/or the resource base is far bigger than Phoenix alone. The "developer's discount" framing is relative to peers, not absolute to NPV.

Contrarian view (what the market refuses to see): The crowd treats the Feb-2026 CNSC approval as having de-risked Phoenix — but permitting and technology are different risks. The licence de-risked the paperwork; the freeze-wall + ISR-at-Athabasca-grade is still a science experiment that only resolves at commissioning in 2027-28. The market has priced the easy de-risking (permits, FID) and is under-pricing the binary that actually matters (does the novel mining method work). That cuts both ways: it's why the stock can re-rate hard on first-solution news — and crater on the first containment headline.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• The single point of failure is the mining method. Bulls hand-wave "successful field test → PoS 70-75%." But a field test is not a production wellfield; freeze-wall containment of an acid leach in fractured Athabasca rock has no production precedent on Earth. Hydrogeologic surprises "only resolve during commissioning". This is not a derisked engineering project; it's a first-of-a-kind pilot at commercial scale.
• Revenue concentration that doesn't exist yet. 100% of the equity's production case is one deposit. There is no diversification, no operating cash flow to cushion a delay. McClean Lake (22.5%, Orano-operated, fed by a competitor's mine) is a rounding error (C$1.1M/q).
• The moat is conditional. "Lowest-cost" is true only if ISR works at planned recoveries; if recoveries undershoot or the freeze plant underperforms, the cost advantage inverts into a stranded, over-budget plant.
• Most dangerous competitor bulls underestimate: not another junior — it's Cameco/Kazatomprom supply discipline and the secondary market (SPUT). If incumbents bring idled capacity (McArthur River, Cigar Lake ramp) and SPUT stops buying, the spot tailwind that supports the whole developer complex reverses — and DNN, the smallest single-asset name, gets hit hardest.
• Capital-allocation/accounting irritants: the US$300M convertible makes earnings unreadable and adds a 2031 dilution/refi overhang; carrying 1.7M lb physical uranium is a leveraged bet dressed as treasury management — great in 2021-24, a drawdown amplifier in a downcycle.
• What must hold for today's ~US$3.10: (a) ISR + freeze wall work at scale; (b) build lands near C$600M and mid-2028; (c) uranium term stays >~$80. If growth/economics disappoint 20-30% (recoveries low, schedule slips, uranium back to $60), the NPV underpinning collapses and the stock retraces toward asset-backing ($1.50-2.00 range, near the lower half of the 52-wk band).
• The one scenario that permanently impairs: freeze-wall/leach containment fails environmental performance at commissioning, triggering CNSC intervention and a redesign — Phoenix becomes uneconomic or massively delayed, and the equity is worth treasury + residual resource, a fraction of today. Plausibility: low-to-moderate, but non-trivial and binary — exactly the risk the post-permit price seems to discount.

Lens 14 · Management Questions (ordered by information value)

1. What are the measured freeze-wall integrity and leach-containment results from the feasibility field test, and what specific commissioning metrics in 2027 would tell us ISR is working at scale — versus the threshold that would trigger a redesign?
2. What is the probability-weighted range for actual ISR uranium recovery vs. the FS assumption, and how does NPV move if recovery comes in 10-20% below plan?
3. After the <C$420M → ~C$600M revision, what is the current contingency in the C$600M, and what is the realistic worst-case capex if commissioning surprises?
4. If commissioning slips past mid-2028, what is the financing plan — and at what uranium price/share price does it become dilutive equity rather than the existing treasury?
5. How should investors read your GAAP/IFRS net loss given the convertible-derivative FV swings — what is the clean cash-burn run-rate through first production?
6. What are the terms and dilution mechanics of the US$300M 2031 convertibles, and how do you manage the 2031 maturity/refi?
7. Of the ~16M lb contracted/in-negotiation, what share is market-related-no-cap vs. floored/ceilinged vs. base-escalated, and what is the blended floor protecting downside?
8. What is the expansion path — Gryphon and the wider Wheeler resource — and its capital sequencing relative to Phoenix cash flow?
9. How do you think about monetising the 1.7M-lb physical uranium — strategic reserve, build funding, or opportunistic sales — and at what price?
10. What is your read on uranium term price durability, and how much of the current ~US$93/lb is utility restocking vs. structural deficit?
11. How exposed is McClean Lake toll-milling revenue to Cigar Lake's (Cameco's) production decisions, and is that 22.5% stake core or sellable?
12. What is the mine plan beyond the first 10 years / 56.7M lb — does Phoenix have a credible life-extension, or is this a decade-long asset?
13. How are you addressing the MiningWatch Canada / community environmental concerns on freeze-wall and groundwater, and what residual permitting risk remains post-CNSC?
14. What capital-return philosophy applies once Phoenix generates free cash flow — reinvest in the district, buy back, or initiate a dividend?
15. What insider-ownership or buying would you point to that signals management conviction, given the recent net selling?

---